Inventor · disambiguated record
Akash Khandelwal
Also filed as: KHANDELWAL AKASH
0 granted patents·5 pending applications·0 citations·filing 2019–2020
Files withMERCK PATENT GMBH5
Top patents by PatentIndex Score
5 records- 0147US2021113656A1Treatment of stage iii nsclc and mitigation of pathological conditions associated with the treatmentMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 0247US2021214446A1Dosing regimens for targeted tgf-b inhibition for use in treating biliary tract cancerMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 0345US2021061899A1Dosing regimens for targeted tgf-b inhibition for use in treating cancer in treatment naïve subjectsMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 0445US2021115145A1Combination therapy with targeted tgf-b inhibition for treatment of advanced non-small cell lung cancerMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 0539US2019330375A1Dosing regimens and dosage forms for targeted tgf-b inhibitionMERCK PATENT GMBH·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Akash Khandelwal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →